Home › Ovarian Epithelial Carcinoma › California
Ovarian Epithelial Carcinoma clinical trials in California
10 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in California.
Cities in California
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- UCLA - University of California Los Angeles Medical Center /ID# 274566, Los Angeles
- Scripps Md Anderson - Prebys Cancer Center /ID# 276891, San Diego
- California Pacific Medical Center - Van Ness Campus /ID# 275329, San Francisco
RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 29, 2026 · NCT06890338ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- University of California, San Diego, La Jolla
- Hoag Memorial Hospital Presbyterian, Newport Beach
- Redwood City, Redwood City
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT05059444AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
- Research Site, La Jolla
RecruitingPhase 3
Ages 18 and older · Women · Updated Jul 21, 2026 · NCT07218809Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- Disney Family Cancer Center, Burbank
- Scripps Clinic, La Jolla
- Palo Alto Medical Foundation, Palo Alto
RecruitingPhase 3
Ages 18 and older · Women · Updated Jul 2, 2026 · NCT06819007Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- Beckman Research Institute of City of Hope, Duarte
- VA Medical Center, Fresno, Fresno
- Santa Clara Valley Medical Center, Fruitdale
- and 5 more
Recruiting
Ages 18 and older · All sexes · Updated Apr 30, 2026 · NCT05297734CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
- City of Hope National Medical Center, Duarte
- Providence St. Jude Medical Center, Fullerton
- UCLA - JCCC Clinical Research Unit, Los Angeles
- and 2 more
RecruitingPhase 2
Ages 18 and older · Women · Updated Dec 23, 2025 · NCT06690775A Study of NX-1607 in Adults With Advanced Malignancies
- University of Southern California, Los Angeles
- University of California, San Francisco, San Francisco
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2025 · NCT05107674Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Moores Cancer Center UC San Diego Health, La Jolla
- Keck School of Medicine of USC, Los Angeles
- UCLA, Los Angeles
- and 1 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 15, 2025 · NCT04429542A Beta-only IL-2 ImmunoTherapY Study
- Sharp Memorial Hospital, San Diego
- Providence Saint John's Health Center, Santa Monica
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 9, 2025 · NCT05086692Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
- UC San Diego Moores Cancer Center, La Jolla
- Stanford University, Stanford
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Feb 8, 2024 · NCT04282044From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.